Related references
Note: Only part of the references are listed.Benzodiazepines and Related Sedatives
Linda Peng et al.
MEDICAL CLINICS OF NORTH AMERICA (2022)
Preventing new episodes of bipolar disorder in adults: Systematic review and meta-analysis of randomized controlled trials
Anastasiya Nestsiarovich et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2022)
Augmentation strategies for treatment resistant major depression: A systematic review and network meta-analysis
Nicolas A. Nunez et al.
JOURNAL OF AFFECTIVE DISORDERS (2022)
The impact of internet-based cognitive behavioral therapy and depressive symptoms on self-care behavior in patients with heart failure: A secondary analysis of a randomised controlled trial
Peter Johansson et al.
INTERNATIONAL JOURNAL OF NURSING STUDIES (2021)
Efficacy of psychological interventions on psychological outcomes in coronary artery disease: systematic review and meta-analysis
Ines Magan et al.
PSYCHOLOGICAL MEDICINE (2021)
The efficacy of cognitive behavioral therapy-based interventions on patients with hypertension: A systematic review and meta-analysis
Yanni Li et al.
PREVENTIVE MEDICINE REPORTS (2021)
Effects of a conventional mood stabilizer alone or in combination with second-generation antipsychotics on recurrence rate and discontinuation rate in bipolar I disorder in the maintenance phase: A systematic review and meta-analysis of randomized, placebo-controlled trials
Taro Kishi et al.
BIPOLAR DISORDERS (2021)
Effects of Cognitive Behavioral Therapy on Pain and Sleep in Adults with Traumatic Brain Injury: A Systematic Review and Meta-Analysis
Xin Li et al.
NEURAL PLASTICITY (2021)
Effectiveness of cognitive behavioral therapy-based interventions on health outcomes in patients with coronary heart disease: A meta-analysis
Yan-Ni Li et al.
WORLD JOURNAL OF PSYCHIATRY (2021)
Depression Associated with Reduced Heart Rate Variability Predicts Outcome in Adult Congenital Heart Disease
Mechthild Westhoff-Bleck et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Toxic epidermal necrolysis and Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in pediatric patients with a focus on newer antiepileptic drugs: A 25-year retrospective study at a single tertiary care center
Kristyna L. Gleghorn et al.
PEDIATRIC DERMATOLOGY (2021)
Prevalence of Mental Disorders and Impact on Quality of Life in Patients With Pulmonary Arterial Hypertension
Karen M. Olsson et al.
FRONTIERS IN PSYCHIATRY (2021)
Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials
Taro Kishi et al.
MOLECULAR PSYCHIATRY (2021)
Socioeconomic deprivation and blood lipids in first-episode psychosis patients with minimal antipsychotic exposure: Implications for cardiovascular risk
Franz Veru-Lesmes et al.
SCHIZOPHRENIA RESEARCH (2020)
Association of Outpatient Practice-Level Socioeconomic Disadvantage With Quality of Care and Outcomes Among Older Adults With Coronary Artery Disease Implications for Value-Based Payment
Rishi K. Wadhera et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2020)
Effects of Cognitive Behavioral Therapy-Based Intervention on Improving Glycaemic, Psychological, and Physiological Outcomes in Adult Patients With Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials
Xiangyun Yang et al.
FRONTIERS IN PSYCHIATRY (2020)
Comorbid depression in medical diseases
Stefan M. Gold et al.
NATURE REVIEWS DISEASE PRIMERS (2020)
Assessment of major mental disorders in a German peripartum cardiomyopathy cohort
Tobias J. Pfeffer et al.
ESC HEART FAILURE (2020)
Metacognitive Therapy for Adjustment Disorder in a Patient With Newly Diagnosed Pulmonary Arterial Hypertension: A Case Report
Lotta Winter et al.
FRONTIERS IN PSYCHOLOGY (2020)
Valproic Acid-Induced Coagulopathy
Riten Kumar et al.
PEDIATRIC NEUROLOGY (2019)
Long-term effectiveness of oral second-generation antipsychotics in patients with schizophrenia and related disorders: a systematic review and meta-analysis of direct head-to-head comparisons
Taishiro Kishimoto et al.
WORLD PSYCHIATRY (2019)
The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness
Joseph Firth et al.
LANCET PSYCHIATRY (2019)
A 60-Year Evolution of Cognitive Theory and Therapy
Aaron T. Beck
PERSPECTIVES ON PSYCHOLOGICAL SCIENCE (2019)
Social Determinants of Health and Preclinical Glycemic Control in Newly Diagnosed First-Episode Psychosis Patients
Franz Veru-Lesmes et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2018)
Hypertension risk and clinical care in patients with bipolar disorder or schizophrenia; a systematic review and meta-analysis
Luis Ayerbe et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Efficacy and safety of levomilnacipran, vilazodone and vortioxetine compared with other second-generation antidepressants for major depressive disorder in adults: A systematic review and network meta-analysis
Gernot Wagner et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Effectiveness of Cognitive Behavioral Therapy for Depression and Anxiety in Patients With Cardiovascular Disease: A Systematic Review and Meta-Analysis
James Reavell et al.
PSYCHOSOMATIC MEDICINE (2018)
Dietary patterns and physical activity in people with schizophrenia and increased waist circumference
Ane Storch Jakobsen et al.
SCHIZOPHRENIA RESEARCH (2018)
Prescription Benzodiazepine Use Among Older Adults: A Critical Review
Lauren B. Gerlach et al.
HARVARD REVIEW OF PSYCHIATRY (2018)
Direct and indirect effects of psychopharmacological treatment on the cardiovascular system
Kai G. Kahl
HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION (2018)
A Systematic Review of Psychological and Pharmacological Treatments for Adjustment Disorder in Adults
Meaghan L. O'Donnell et al.
JOURNAL OF TRAUMATIC STRESS (2018)
Risk factors for QTc-prolongation: systematic review of the evidence
Eline Vandael et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2017)
Treatment of neurocognitive symptoms in unipolar depression: A systematic review and future perspectives
E. Salagre et al.
JOURNAL OF AFFECTIVE DISORDERS (2017)
Psychotropic drugs and ventricular repolarisation: The effects on QT interval, T-peak to T-end interval and QT dispersion
Tiziano Acciavatti et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
Effects of psychopharmacological treatment with antidepressants on the vascular system
Kai G. Kahl et al.
VASCULAR PHARMACOLOGY (2017)
Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls
Christoph U. Correll et al.
WORLD PSYCHIATRY (2017)
Impaired Glucose Homeostasis in First-Episode Schizophrenia A Systematic Review and Meta-analysis
Toby Pillinger et al.
JAMA PSYCHIATRY (2017)
Cholesterol and triiglyceride levels first-episode psychosis systematic review and meta analysis
Toby Pillinger et al.
BRITISH JOURNAL OF PSYCHIATRY (2017)
Current and Future Perspectives on the Major Depressive Disorder: Focus on the New Multimodal Antidepressant Vortioxetine
Laura Orsolini et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2017)
Antidepressant Use Is Associated With an Increased Risk of Developing Microbleeds
Saloua Akoudad et al.
STROKE (2016)
Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials
Marco Solmi et al.
CNS SPECTRUMS (2016)
H1-histamine receptor affinity predicts weight gain with antidepressants
Virginio Salvi et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
Cardiovascular safety of antipsychotics: a clinical overview
Christoffer Polcwiartek et al.
EXPERT OPINION ON DRUG SAFETY (2016)
First-generation antipsychotics and QTc: any role for mediating variables?
Giuseppe Carra et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2016)
The Effect of Guided Web-Based Cognitive Behavioral Therapy on Patients With Depressive Symptoms and Heart Failure: A Pilot Randomized Controlled Trial
Johan Gustav Lundgren et al.
JOURNAL OF MEDICAL INTERNET RESEARCH (2016)
Autonomic nervous system dysfunction in psychiatric disorders and the impact of psychotropic medications: a systematic review and meta-analysis
Gail A. Alvares et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2016)
Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis
Davy Vancampfort et al.
WORLD PSYCHIATRY (2016)
Antidepressants and the risk of hyponatremia: a Danish register-based population study
Katja Biering Leth-Moller et al.
BMJ OPEN (2016)
Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval
Corrado Barbui et al.
PLOS ONE (2016)
Risk of Ventricular Arrhythmia with Citalopram and Escitalopram: A Population-Based Study
Elena Qirjazi et al.
PLOS ONE (2016)
Drug-induced QT interval prolongation and torsades de pointes: Role of the pharmacist in risk assessment, prevention and management
James E. Tisdale
CANADIAN PHARMACISTS JOURNAL (2016)
Use of selective serotonin re-uptake inhibitors and the heart rate corrected QT interval in a real-life setting: the population-based Rotterdam Study
Nevena M. Maljuric et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Antipsychotic Polypharmacy and Corrected QT Interval: A Systematic Review
Hiroyoshi Takeuchi et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2015)
Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder
Christoph U. Correll et al.
WORLD PSYCHIATRY (2015)
Risk of intracranial haemorrhage in antidepressant users with concurrent use of non-steroidal anti-inflammatory drugs: nationwide propensity score matched study
Ju-Young Shin et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Risk of intracranial haemorrhage in antidepressant users with concurrent use of non-steroidal anti-inflammatory drugs: nationwide propensity score matched study
Ju-Young Shin et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Metabolic issues in patients affected by schizophrenia: clinical characteristics and medical management
Antonio Ventriglio et al.
FRONTIERS IN NEUROSCIENCE (2015)
Antipsychotic Medication and QT Prolongation
Paramdip Singh Chohan et al.
PAKISTAN JOURNAL OF MEDICAL SCIENCES (2015)
Cognitive behavioral therapy: Current status and future research directions
Shelley Mcmain et al.
PSYCHOTHERAPY RESEARCH (2015)
Levomilnacipran for the treatment of major depressive disorder: a review
Gregory M. Asnis et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2015)
Effect of Selective Serotonin Reuptake Inhibitors on Bleeding Risk in Patients With Atrial Fibrillation Taking Warfarin
Gene R. Quinn et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
Risk of QT/QTc Prolongation Among Newer Non-SSRI Antidepressants
Natalia M. Jasiak et al.
ANNALS OF PHARMACOTHERAPY (2014)
Anti-anxiety drugs use and cardiovascular outcomes in patients with myocardial infarction: A national wide assessment
Cho-Kai Wu et al.
ATHEROSCLEROSIS (2014)
QTc Interval Prolongation and Torsade de Pointes Associated with Second-Generation Antipsychotics and Antidepressants: A Comprehensive Review
Mehrul Hasnain et al.
CNS DRUGS (2014)
Depression and cardiovascular disease: a clinical review
David L. Hare et al.
EUROPEAN HEART JOURNAL (2014)
A review of the clinical efficacy, safety and tolerability of the antidepressants vilazodone, levomilnacipran and vortioxetine
William James Deardorff et al.
EXPERT OPINION ON PHARMACOTHERAPY (2014)
Cardiovascular adverse effects of newer antidepressants
Rajnish Mago et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2014)
A study of the safety and harms of antidepressant drugs for older people: a cohort study using a large primary care database
CAC Coupland et al.
HEALTH TECHNOLOGY ASSESSMENT (2014)
Meta-Analysis of Selective Serotonin Reuptake Inhibitor-Associated QTc Prolongation
Scott R. Beach et al.
JOURNAL OF CLINICAL PSYCHIATRY (2014)
Cerebral Venous Sinus Thrombosis May Be Associated With Clozapine
David Werring et al.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2014)
QTc Prolongation with Antipsychotics: Is Routine ECG Monitoring Recommended?
Asim A. Shah et al.
JOURNAL OF PSYCHIATRIC PRACTICE (2014)
Antidepressants and the Risk of Hyponatremia: A Class-by-Class Review of Literature
Livia De Picker et al.
PSYCHOSOMATICS (2014)
Guided Internet-based vs. face-to-face cognitive behavior therapy for psychiatric and somatic disorders: a systematic review and meta-analysis
Gerhard Andersson et al.
WORLD PSYCHIATRY (2014)
Neuropsychological Factors and Bariatric Surgery: A Review
Patricia Casey
CURRENT PSYCHIATRY REPORTS (2014)
Increased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventions
Petter Andreas Ringen et al.
FRONTIERS IN PSYCHIATRY (2014)
A Comparison of the Risk of QT Prolongation Among SSRIs
Kylee A. Funk et al.
ANNALS OF PHARMACOTHERAPY (2013)
The cardiovascular safety profile of escitalopram
Michael E. Thase et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)
Efficacy and safety of second-generation long-acting injections in schizophrenia: a meta-analysis of randomized-controlled trials
Paolo Fusar-Poli et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2013)
Termination of Clozapine Treatment Due to Medical Reasons: When Is It Warranted and How Can It Be Avoided?
Jimmi Nielsen et al.
JOURNAL OF CLINICAL PSYCHIATRY (2013)
Effects of Selective Serotonin Reuptake Inhibitors Versus Tricyclic Antidepressants on Cerebrovascular Events A Nationwide Population-Based Cohort Study
Yen-Chieh Lee et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2013)
A Thorough QTc Study of 3 Doses of Iloperidone Including Metabolic Inhibition Via CYP2D6 and/or CYP3A4 and a Comparison to Quetiapine and Ziprasidone
Steven G. Potkin et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2013)
QTc Prolongation, Torsades de Pointes, and Psychotropic Medications
Scott R. Beach et al.
PSYCHOSOMATICS (2013)
Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders-A Systematic Review and Meta-Analysis
Alex J. Mitchell et al.
SCHIZOPHRENIA BULLETIN (2013)
QT interval and antidepressant use: a cross sectional study of electronic health records
Victor M. Castro et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
QT prolongation: A critical adverse effect of some medications
Larissa DeDea
JAAPA-Journal of the American Academy of Physician Assistants (2013)
Differences in the prescribing of medication for physical disorders in individuals with v. without mental illness: meta-analysis
Alex J. Mitchell et al.
BRITISH JOURNAL OF PSYCHIATRY (2012)
Hyponatraemia during psychopharmacological treatment: results of a drug surveillance programme
Martin Letmaier et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2012)
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
Marc De Hert et al.
NATURE REVIEWS ENDOCRINOLOGY (2012)
Epidemiologic Evaluation of Cardiovascular Risk in Patients Receiving Milnacipran, Venlafaxine, or Amitriptyline: Evidence from French Health Data
Philip J. Mease et al.
ANNALS OF PHARMACOTHERAPY (2011)
Depression and Cardiac Disease A Review
Christopher M. Celano et al.
CARDIOLOGY IN REVIEW (2011)
Antipsychotic Pharmacotherapy and Orthostatic Hypotension Identification and Management
James J. Gugger
CNS DRUGS (2011)
QTc Prolongation by Psychotropic Drugs and the Risk of Torsade de Pointes
Katharina Wenzel-Seifert et al.
DEUTSCHES ARZTEBLATT INTERNATIONAL (2011)
Antipsychotic Drug Administration Does Not Correlate with Prolonged Rate-Corrected QT Interval in Children and Adolescents: Results from a Nested Case-Control Study
Christoph U. Correll et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2011)
Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies
Alex J. Mitchell et al.
LANCET ONCOLOGY (2011)
Cardiologic side effects of psychotropic drugs
Giuseppe Marano et al.
JOURNAL OF GERIATRIC CARDIOLOGY (2011)
Antidepressant use and risk of adverse outcomes in older people: population based cohort study
Carol Coupland et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
The importance of venous thromboembolism - a physical consequence of psychiatric treatments
G. Stansby et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2010)
Serotonin Reuptake Inhibitor Antidepressants and Abnormal Bleeding: A Review for Clinicians and a Reconsideration of Mechanisms
Chittaranjan Andrade et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Selective serotonin reuptake inhibitors provide significant lower re-hospitalization rates in patients recovering from acute coronary syndromes: evidence from a meta-analysis
Marianna Mazza et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Antipsychotics Associated with the Development of Type 2 Diabetes in Antipsychotic-Naive Schizophrenia Patients
Jimmi Nielsen et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Valproic Acid Monotherapy in Pregnancy and Major Congenital Malformations.
Janneke Jentink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Antipsychotic drugs and risk of venous thromboembolism: nested case-control study
Chris Parker et al.
BRITISH MEDICAL JOURNAL (2010)
An Integrated Approach to the Diagnosis and Treatment of Anxiety Within the Practice of Cardiology
David Janeway
CARDIOLOGY IN REVIEW (2009)
Antidepressants and Falls in the Elderly
Adam Darowski et al.
DRUGS & AGING (2009)
Psychotropic Drugs Associated With Corrected QT Interval Prolongation
Charlotte van Noord et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2009)
Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death
Wayne A. Ray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
High incidence of vaproate-induced coagulation disorders in children receiving valproic acid: a prospective study
Stephan Koenig et al.
BLOOD COAGULATION & FIBRINOLYSIS (2008)
Assessment of risk of venous thromboembolism and its possible prevention in psychiatric patients
Radovan Maly et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2008)
Treatment of post-myocardial infarction depressive disorder: A randomized, placebo-controlled trial with mirtazapine
Adriaan Honig et al.
PSYCHOSOMATIC MEDICINE (2007)
A retrospective pooled analysis of duloxetine safety in 23 983 subjects
James Gahimer et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Bupropion for smokers hospitalized with acute cardiovascutar disease
Nancy A. Rigotti et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Assessment and treatment of depression in patients with cardiovascular disease:: National Heart, Lung, and Blood Institute working group report
Karina W. Davidson et al.
PSYCHOSOMATIC MEDICINE (2006)
Lithium: Clinical considerations in internal medicine
Marlene P. Freeman et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Depression after myocardial infarction is a risk factor for declining health related quality of life and increased disability and cardiac complaints at 12 months
P de Jonge et al.
HEART (2006)
Venous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agents
R Liperoti et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Depression following acute myocardial infarction: A prospective relationship with ongoing health and function
JA Fauerbach et al.
PSYCHOSOMATICS (2005)
Left atrial thrombosis associated with antipsychotic drugs
S Numata et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2005)
Severe adverse drug reactions of antidepressants:: Results of the German multicenter drug surveillance program AMSP
D Degner et al.
PHARMACOPSYCHIATRY (2004)
A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition
EP Harrigan et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2004)
Consensus development conference on antipsychotic drugs and obesity and diabetes
DIABETES CARE (2004)
Two cases of deep vein thrombosis associated with antipsychotic drug use
M Matsumoto et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2004)
Cardiovascular side effects of new antidepressants and antipsychotics: New drugs, old concerns?
P Pacher et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Treatment of anxiety and depression in transplant patients - Pharmacokinetic considerations
CC Crone et al.
CLINICAL PHARMACOKINETICS (2004)
Comparing symptoms of depression and anxiety as predictors of cardiac events and increased health care consumption after myocardial infarction
JJMH Strik et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Olanzapine and venous thromboembolism
S Hägg et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2003)
Epidemiology of comorbid coronary artery disease and depression
B Rudisch et al.
BIOLOGICAL PSYCHIATRY (2003)
Bupropion poisoning: a case series
CR Balit et al.
MEDICAL JOURNAL OF AUSTRALIA (2003)
Induced QT prolongation and torsades de pointes
YG Yap et al.
HEART (2003)
Antipsychotic-related QTc prolongation, Torsade de Pointes and sudden death
PM Haddad et al.
DRUGS (2002)
Hyponatraemia in elderly psychiatric patients treated with Selective Serotonin Reuptake Inhibitors and venlafaxine: a retrospective controlled study in an inpatient unit
D Kirby et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2002)
Antipsychotic medication and venous thrombosis
R Thomassen et al.
BRITISH JOURNAL OF PSYCHIATRY (2001)
Smoking and mental illness - A population-based prevalence study
K Lasser et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study
GL Zornberg et al.
LANCET (2000)
Role of cytochrome P450 2D6 (CYP2D6) in the stereospecific metabolism of E- and Z-doxepin
VS Haritos et al.
PHARMACOGENETICS (2000)
Antipsychotic drugs and venous thromboembolism
JF Knudson et al.
LANCET (2000)
The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke
R Rosmond et al.
JOURNAL OF INTERNAL MEDICINE (2000)
Share Paper
